OHSU researchers have established the Knight Cardiovascular Institute Epigenetics Consortium to foster research and education in epigenetics.
This team of experts assists investigators with the analysis of epigenetic regulation by combining evolving technologies and high-throughput sequencing. Services offered include bisulfite sequencing for DNA methylation, ChIP-seq (histone marks or transcription factors), ATAC-seq, and RNA-seq. The epigenetic consortium supports projects from start to finish, including study design, assays, bioinformatic analyses, and help with interpretation of the results.
Email Lucia Carbone for more information.